{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:10:44Z","timestamp":1758478244785},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s11906-016-0680-3","type":"journal-article","created":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T00:30:02Z","timestamp":1475541002000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effects of Antihypertensive Therapy on Blood Pressure Variability"],"prefix":"10.1007","volume":"18","author":[{"given":"Kazuo","family":"Eguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,4]]},"reference":[{"key":"680_CR1","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/ajh.2012.75","volume":"25","author":"K Eguchi","year":"2012","unstructured":"Eguchi K, Hoshide S, Schwartz JE, Shimada K, Kario K. Visit-to-visit and ambulatory blood pressure variability as predictors of incident cardiovascular events in patients with hypertension. Am J Hypertens. 2012;25:962\u20138.","journal-title":"Am J Hypertens"},{"key":"680_CR2","doi-asserted-by":"crossref","unstructured":"Muntner P, Whittle J, Lynch AI, Colantonio LD, Simpson LM, Einhorn PT, et al. Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure, and mortality. A cohort study. Ann Intern Med. 2015;163:329\u201338. In the Post hoc analysis of ALLHAT study, higher VVV of SBP was associated with an increased risk for cardiovascular disease and mortality.","DOI":"10.7326\/M14-2803"},{"key":"680_CR3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)60308-X","volume":"375","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Howard SC, Dolan E, O\u2019Brien E, Dobson JE, Dahl\u00f6f B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895\u2013905.","journal-title":"Lancet"},{"key":"680_CR4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/HYPERTENSIONAHA.114.03903","volume":"64","author":"KM Diaz","year":"2014","unstructured":"Diaz KM, Tanner RM, Falzon L, Levitan EB, Reynolds K, Shimbo D, et al. Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis. Hypertension. 2014;64:965\u201382.","journal-title":"Hypertension"},{"key":"680_CR5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2013.11.071","volume":"233","author":"M Nagai","year":"2014","unstructured":"Nagai M, Hoshide S, Nishikawa M, Masahisa S, Kario K. Visit-to-visit blood pressure variability in the elderly: associations with cognitive impairment and carotid artery remodeling. Atherosclerosis. 2014;233:19\u201326.","journal-title":"Atherosclerosis"},{"key":"680_CR6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(10)70066-1","volume":"9","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Howard SC, Dolan E, O\u2019Brien E, Dobson JE, Dahl\u00f6f B, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9:469\u201380.","journal-title":"Lancet Neurol"},{"key":"680_CR7","doi-asserted-by":"crossref","unstructured":"Smith TR, Drozda JP, Vanslette JA, Hoeffken AS, Nicholson RA. Medication class effects on visit-to-visit variability of blood pressure measurements: analysis of electronic health record data in the \u201creal world\u201d. J Clin Hypertens (Greenwich). 2013;15:655\u201362. From the Mercy EpicCare EHR-Derived Database (MEDD) (n=183,374) who had at least 4 outpatient visits with BP readings, diuretics and calcium channel blockers were associated with lower VVV, while alpha-\/beta-blockers were associated with higher VVV.","DOI":"10.1111\/jch.12165"},{"key":"680_CR8","doi-asserted-by":"crossref","unstructured":"Sato N, Saijo Y, Sasagawa Y, Morimoto H, Takeuchi T, Sano H, et al. Visit-to-visit variability and seasonal variation in blood pressure: Combination of Antihypertensive Therapy in the Elderly, Multicenter Investigation (CAMUI) Trial subanalysis. Clin Exp Hypertens. 2015;37:411\u20139. In the subanalysis of the combination of Antihypertensive Therapy in the Elderly, Multicenter Investigation (CAMUI) Trial, combination therapy with an ARB plus a CCB was better than that with an ARB plus diuretics for decreasing BP variability.","DOI":"10.3109\/10641963.2014.995802"},{"key":"680_CR9","doi-asserted-by":"crossref","unstructured":"Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T, et al. Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial. Hypertens Res. 2016;39:46\u201353. In the post hoc analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) trial, the benidipine-thiazide combination may reduce visit-to-visit BP variability more than the benidipine- beta-blocker combination.","DOI":"10.1038\/hr.2015.104"},{"key":"680_CR10","doi-asserted-by":"crossref","unstructured":"Vishram JKK, Dahl\u00f6f B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, et al. Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage: a LIFE substudy. J Hypertens. 2015;33:2422\u201330. In the subanalysis of the LIFE study, visit-to-visit variability in BP predicted cardiovascular events in treated hypertensive patients with left ventricular hypertrophy (LVH), but no statistical difference was observed between the two treatment arms, losartan-based and atenolol-based treatments, probably most patients were taking CCB.","DOI":"10.1097\/HJH.0000000000000739"},{"key":"680_CR11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/clpt.2010.171","volume":"88","author":"LG Osterberg","year":"2010","unstructured":"Osterberg LG, Urquhart J, Blaschke TF. Understanding forgiveness: minding and mining the gaps between pharmacokinetics and therapeutics. Clin Pharmacol Ther. 2010;88:457\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"680_CR12","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/HYPERTENSIONAHA.107.104620","volume":"52","author":"M Kikuya","year":"2008","unstructured":"Kikuya M, Ohkubo T, Metoki H, Asayama K, Hara A, Obara T, et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension. 2008;52:1045\u201350.","journal-title":"Hypertension"},{"key":"680_CR13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/HYPERTENSIONAHA.111.178657","volume":"59","author":"JK Johansson","year":"2012","unstructured":"Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home Study. Hypertension. 2012;59:212\u20138.","journal-title":"Hypertension"},{"key":"680_CR14","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/HYPERTENSIONAHA.111.171645","volume":"57","author":"Y Matsui","year":"2011","unstructured":"Matsui Y, Ishikawa J, Eguchi K, Shibasaki S, Shimada K, Kario K. Maximum value of home blood pressure: a novel indicator of target organ damage in hypertension. Hypertension. 2011;57:1087\u201393.","journal-title":"Hypertension"},{"key":"680_CR15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/hr.2012.177","volume":"36","author":"M Fukui","year":"2013","unstructured":"Fukui M, Ushigome E, Tanaka M, Hamaguchi M, Tanaka T, Atsuta H, et al. Home blood pressure variability on one occasion is a novel factor associated with arterial stiffness in patients with type 2 diabetes. Hypertens Res. 2013;36:219\u201325.","journal-title":"Hypertens Res"},{"key":"680_CR16","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/hr.2011.128","volume":"34","author":"E Ushigome","year":"2011","unstructured":"Ushigome E, Fukui M, Hamaguchi M, Senmaru T, Sakabe K, Tanaka M, et al. The coefficient variation of home blood pressure is a novel factor associated with macroalbuminuria in type 2 diabetes mellitus. Hypertens Res. 2011;34:1271\u20135.","journal-title":"Hypertens Res"},{"key":"680_CR17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/hr.2014.24","volume":"37","author":"N Karpettas","year":"2014","unstructured":"Karpettas N, Destounis A, Kollias A, Nasothimiou E, Moyssakis I, Stergiou GS. Prediction of treatment-induced changes in target-organ damage using changes in clinic, home and ambulatory blood pressure. Hypertens Res. 2014;37:543\u20137.","journal-title":"Hypertens Res"},{"key":"680_CR18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/10641963.2012.681087","volume":"34","author":"K Ishikura","year":"2012","unstructured":"Ishikura K, Obara T, Kato T, Kikuya M, Shibamiya T, Shinki T, et al. Associations between day-by-day variability in blood pressure measured at home and antihypertensive drugs: the J-HOME-Morning study. Clin Exp Hypertens. 2012;34:297\u2013304.","journal-title":"Clin Exp Hypertens"},{"key":"680_CR19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/FJC.0b013e31804d1cf1","volume":"49","author":"K Eguchi","year":"2007","unstructured":"Eguchi K, Tomizawa H, Ishikawa J, Hoshide S, Fukuda T, Numao T, et al. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure. J Cardiovasc Pharmacol. 2007;49:394\u2013400.","journal-title":"J Cardiovasc Pharmacol"},{"key":"680_CR20","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/HYPERTENSIONAHA.111.189217","volume":"59","author":"Y Matsui","year":"2012","unstructured":"Matsui Y, O\u2019Rourke MF, Hoshide S, Ishikawa J, Shimada K, Kario K. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study. Hypertension. 2012;59:1132\u20138.","journal-title":"Hypertension"},{"key":"680_CR21","doi-asserted-by":"crossref","unstructured":"Asayama K, Ohkubo T, Hanazawa T, Watabe D, Hosaka M, Satoh M, et al. Does antihypertensive drug class affect day-to-day variability of self-measured home blood pressure? The HOMED\u2010BP Study. J Am Heart Assoc Cardiovasc Cerebrovasc Dis. 2016;5, e002995. In the subanalysis of the HOMED-BP study, amlodipine reduced morning systolic BPV more than the other CCBs. The effects of antihypertensive drug classes on day-by-day BPV were similar and no significant impact on prognosis.","DOI":"10.1161\/JAHA.115.002995"},{"key":"680_CR22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/HYPERTENSIONAHA.107.090084","volume":"50","author":"A Tatasciore","year":"2007","unstructured":"Tatasciore A, Renda G, Zimarino M, Soccio M, Bilo G, Parati G, et al. Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension. 2007;50:325\u201332.","journal-title":"Hypertension"},{"key":"680_CR23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00126097-200106000-00002","volume":"6","author":"KS Kristensen","year":"2001","unstructured":"Kristensen KS, H\u00f8egholm A, Bang LE, Gustavsen PH, Poulsen CB. No impact of blood pressure variability on microalbuminuria and left ventricular geometry: analysis of daytime variation, diurnal variation and \u2018white coat\u2019 effect. Blood Press Monit. 2001;6:125\u201331.","journal-title":"Blood Press Monit"},{"key":"680_CR24","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/01.HYP.36.5.901","volume":"36","author":"M Kikuya","year":"2000","unstructured":"Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension. 2000;36:901\u20136.","journal-title":"Hypertension"},{"key":"680_CR25","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00004872-199310000-00019","volume":"11","author":"A Frattola","year":"1993","unstructured":"Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens. 1993;11:1133\u20137.","journal-title":"J Hypertens"},{"key":"680_CR26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ajh.2008.294","volume":"22","author":"K Eguchi","year":"2009","unstructured":"Eguchi K, Ishikawa J, Hoshide S, Pickering TG, Schwartz JE, Shimada K, et al. Night time blood pressure variability is a strong predictor for cardiovascular events in patients with type 2 diabetes. Am J Hypertens. 2009;22:46\u201351.","journal-title":"Am J Hypertens"},{"key":"680_CR27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.amjhyper.2006.07.017","volume":"20","author":"P Verdecchia","year":"2007","unstructured":"Verdecchia P, Angeli F, Gattobigio R, Rapicetta C, Reboldi G. Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension. Am J Hypertens. 2007;20:154\u201361.","journal-title":"Am J Hypertens"},{"key":"680_CR28","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1291\/hypres.28.847","volume":"28","author":"K Eguchi","year":"2005","unstructured":"Eguchi K, Tachikawa Y, Kashima R, Shinohara M, Fukushima F, Sato T, et al. A case of vertebral artery dissection associated with morning blood pressure surge. Hypertens Res. 2005;28:847\u201351.","journal-title":"Hypertens Res"},{"key":"680_CR29","doi-asserted-by":"crossref","unstructured":"Lin Q-S, Ping C, Lin Y-X, Lin Z-Y, Yu L-H, Dai L-S, et al. Systolic blood pressure variability is a novel risk factor for rebleeding in acute subarachnoid hemorrhage: a case\u2013control study. Medicine. 2016;95, e3028. In the retrospective study of 47 patients with subarachnoid hemorrhage (SAH), systolic BPV was associated with increased rates of acute aneurysmal rebleeding.","DOI":"10.1097\/MD.0000000000003028"},{"key":"680_CR30","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/HYPERTENSIONAHA.109.135905","volume":"54","author":"H Kudo","year":"2009","unstructured":"Kudo H, Kai H, Kajimoto H, Koga M, Takayama N, Mori T, et al. Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II system-mediated chronic inflammation. Hypertension. 2009;54:832\u20138.","journal-title":"Hypertension"},{"key":"680_CR31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.atherosclerosis.2009.04.005","volume":"207","author":"H Mitsuhashi","year":"2009","unstructured":"Mitsuhashi H, Tamura K, Yamauchi J, Ozawa M, Yanagi M, Dejima T, et al. Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis. Atherosclerosis. 2009;207:186\u201390.","journal-title":"Atherosclerosis"},{"key":"680_CR32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/01.HYP.36.4.622","volume":"36","author":"A Frattola","year":"2000","unstructured":"Frattola A, Parati G, Castiglioni P, Paleari F, Ulian L, Rovaris G, et al. Lacidipine and blood pressure variability in diabetic hypertensive patients. Hypertension. 2000;36:622\u20138.","journal-title":"Hypertension"},{"key":"680_CR33","doi-asserted-by":"crossref","unstructured":"Eguchi K, Imaizumi Y, Kaihara T, Hoshide S, Kario K, . Comparison of valsartan and amlodipine on ambulatory blood pressure variability in hypertensive patients. Clin Exp Hypertens 2016; in press. In 76 untreated subjects with essential hypertension, CCB monotherapy was better in reducing ambulatory BPV than ARB monotherapy.","DOI":"10.1080\/10641963.2016.1200609"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-016-0680-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-016-0680-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-016-0680-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T06:53:49Z","timestamp":1568444029000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-016-0680-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["680"],"URL":"https:\/\/doi.org\/10.1007\/s11906-016-0680-3","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10]]},"article-number":"75"}}